Expansion Therapeutics

Provider of small molecule binders transformative oral medicines intended to treat severe RNa-mediated diseases. The company's technology is a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications, enabling medical companies to provide treatment options for patients.

Kleiner Perkins

🏥 Healthcare